2022 - Research.com Immunology in Germany Leader Award
2002 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Internal Medicine and Dermatology
His scientific interests lie mostly in Immunology, Internal medicine, Gastroenterology, Hepatitis and Hepatitis C virus. His research investigates the link between Immunology and topics such as Virology that cross with problems in Antibody. His Internal medicine research is multidisciplinary, relying on both Endocrinology and Ribavirin.
The various areas that Michael P. Manns examines in his Ribavirin study include Interferon alfa, Alpha interferon and Viral load. His Gastroenterology research integrates issues from Odds ratio, Primary sclerosing cholangitis and Surgery. His Cirrhosis research incorporates themes from Fibrosis, Pathology, Hepatocellular carcinoma and Liver disease.
His primary areas of investigation include Internal medicine, Immunology, Gastroenterology, Virology and Liver transplantation. His studies in Internal medicine integrate themes in fields like Endocrinology, Ribavirin and Surgery. His work in Autoimmune hepatitis, Hepatitis, Hepatitis C virus, Immune system and Autoantibody is related to Immunology.
Michael P. Manns has included themes like Hepatitis C and Viral load in his Hepatitis C virus study. His work in Gastroenterology is not limited to one particular discipline; it also encompasses Primary sclerosing cholangitis. In his study, HBsAg is inextricably linked to Hepatitis B, which falls within the broad field of Hepatitis B virus.
Internal medicine, Gastroenterology, Immunology, Cirrhosis and In patient are his primary areas of study. His Internal medicine research focuses on Liver transplantation, Hepatitis C, Primary sclerosing cholangitis, Cohort and Retrospective cohort study. His Hepatitis C course of study focuses on Hepatitis C virus and Viral load.
Specifically, his work in Gastroenterology is concerned with the study of Liver disease. His Cirrhosis research incorporates elements of Clinical endpoint and Ascites. His study in Immune system is interdisciplinary in nature, drawing from both HBsAg and Hepatitis B.
Michael P. Manns spends much of his time researching Internal medicine, Gastroenterology, Immunology, Cirrhosis and Hepatitis C. His Internal medicine research includes elements of Oncology and Sofosbuvir. His Gastroenterology study integrates concerns from other disciplines, such as Primary sclerosing cholangitis and Hazard ratio.
His study in Immune system, Antigen, Hepatitis, Hepatitis B virus and Autoimmune hepatitis falls under the purview of Immunology. His work deals with themes such as Acute kidney injury, Quality of life and Incidence, which intersect with Cirrhosis. The Hepatitis C study which covers Hepatitis C virus that intersects with Liver function and Receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.
Michael P. Manns;John G. McHutchison;Stuart C. Gordon;Vinod K. Rustgi.
The Lancet (2001)
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
F. Alvarez;P. A. Berg;F. B. Bianchi;L. Bianchi.
Journal of Hepatology (1999)
Classification of chronic hepatitis: diagnosis, grading and staging.
Valeer J. Desmet;Michael Gerber;Jay H. Hoofnagle;Michael Manns.
Diagnosis and management of autoimmune hepatitis.
Michael P. Manns;Albert J. Czaja;James D. Gorham;Edward L. Krawitt.
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.
Adriaan J. van der Meer;Bart J. Veldt;Jordan J. Feld;Heiner Wedemeyer.
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.
Thierry Poynard;John McHutchison;Michael Manns;Christian Trepo.
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B
Patrick Marcellin;E Jenny Heathcote;Maria Buti;Ed Gane.
The New England Journal of Medicine (2008)
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
John G. McHutchison;Michael Manns;Keyur Patel;Thierry Poynard.
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif.
The Lancet Gastroenterology & Hepatology (2017)
Treatment of Acute Hepatitis C with Interferon Alfa-2b
Elmar Jaeckel;Markus Cornberg;Heiner Wedemeyer;Teresa Santantonio.
The New England Journal of Medicine (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: